Comparative Outcomes of Primary Sclerosing Cholangitis With and Without Comorbid Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Dig Dis SciMay 5, 2026 (epub)
Clinical ResearchGastroenterologyOpen access

Bachviet Nguyen, Stephanie Quon, Daljeet Chahal

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated clinical outcomes in 23,837 patients with primary sclerosing cholangitis (PSC), comparing those with inflammatory bowel disease (IBD) to those without. The study found that PSC-IBD is associated with a significant decrease in all-cause mortality or liver transplantation (HR 0.77, 95% CI 0.62-0.97).

Key findings

  • PSC-IBD patients had a lower risk of all-cause mortality or liver transplantation (HR 0.77, 95% CI 0.62-0.97).
  • Patients with PSC and Crohn's disease had a significantly lower risk of all-cause mortality or liver transplantation (HR 0.67, 95% CI 0.54-0.84).
  • PSC-IBD was associated with an increased risk of hepatopancreatobiliary cancer (HR 2.37, 95% CI 1.35-4.15).
  • No significant difference in risk of recurrent PSC was found between PSC-IBD and PSC only.

Why it matters

Understanding the comparative outcomes of PSC with and without IBD is crucial for risk stratification and management of patients. This study provides insights that may influence clinical decision-making regarding monitoring and treatment strategies.

Source

Published in Dig Dis Sci. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.